Mineralocorticoid receptor antagonism as an add-on treatment for resistant hypertension

被引：0
|
作者：
Rossi, Gian Paolo [1 ]
Maiolino, Giuseppe [1 ]
机构：
[1] Univ Padua, Dept Med DIMED, Padua, Italy
来源：
HYPERTENSION RESEARCH | 2014年 / 37卷 / 12期
关键词：
BLOOD-PRESSURE; SPIRONOLACTONE; PREVALENCE;
D O I：
10.1038/hr.2014.139
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1029 / 1031
页数：3
相关论文
共 50 条
  • [21] Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats
    Tu, Ly
    Thuillet, Raphael
    Perrot, Julie
    Ottaviani, Mina
    Ponsardin, Emy
    Kolkhof, Peter
    Humbert, Marc
    Viengchareun, Say
    Lombes, Marc
    Guignabert, Christophe
    HYPERTENSION, 2022, 79 (10) : 2262 - 2273
  • [22] Adrenocorticotrophin-induced hypertension: effects of mineralocorticoid and glucocorticoid receptor antagonism
    Li, M
    Wen, C
    Fraser, T
    Whitworth, JA
    JOURNAL OF HYPERTENSION, 1999, 17 (03) : 419 - 426
  • [23] Resistant hypertension: cardiorenal protection with mineralocorticoid receptor blockade
    Pitt, Bertram
    Bakris, George L.
    EUROPEAN HEART JOURNAL, 2024, 45 (02) : 136 - 138
  • [24] ROLE OF MINERALOCORTICOID RECEPTOR BLOCKERS IN RESISTANT AND REFRACTORY HYPERTENSION
    Oparil, Suzanne
    JOURNAL OF HYPERTENSION, 2023, 41 : E11 - E11
  • [25] Resistant Hypertension Mineralocorticoid Receptor Antagonist or Renal Denervation?
    Carey, Robert M.
    HYPERTENSION, 2016, 67 (02) : 278 - 280
  • [26] Antagonism in the human mineralocorticoid receptor
    Fagart, J
    Wurtz, JM
    Souque, A
    Hellal-Levy, C
    Moras, D
    Rafestin-Oblin, ME
    EMBO JOURNAL, 1998, 17 (12): : 3317 - 3325
  • [27] A meta-analysis of add-on use of spironolactone in patients with resistant hypertension
    Zhao, Di
    Liu, Hui
    Dong, Pingshuan
    Zhao, Jingdong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 233 : 113 - 117
  • [28] Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists
    Daniel Glicklich
    William H. Frishman
    Drugs, 2015, 75 : 473 - 485
  • [29] Drug Therapy of Apparent Treatment-Resistant Hypertension: Focus on Mineralocorticoid Receptor Antagonists
    Glicklich, Daniel
    Frishman, William H.
    DRUGS, 2015, 75 (05) : 473 - 485
  • [30] Risperidone vs. olanzapine as add-on treatment in treatment resistant depression
    Levitt, AJ
    Chaput, Y
    Lam, R
    Enns, M
    Schaffer, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S343 - S343
12345